GlassScriptPhysician profile
Suk Hong
NPI 1558756726
$3,951.48
in general payments reported to CMS, 2019-2025
22 companies · $776 in 2025
The $776 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $269 · 2021: $23.43 · 2022: $20.00 · 2023: $1,870 · 2024: $993 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,044 · Travel and Lodging: $366 · Education: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,043.78 |
| Travel and Lodging | $366.27 |
| Education | $229.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,344.15 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Synergy Ablation System |
| Edwards Lifesciences Corporation | $836.26 | 2021-2024 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $274.50 | 2023-2025 | Na, Corevalve Evolut R |
| Medtronic Vascular, INC. | $269.00 | 2020 | |
| Zimmer Biomet Holdings, INC. | $215.03 | 2023-2025 | Sternalock 360 System, Traumaone |
| Abiomed | $198.54 | 2024 | Impella |
| Davol INC. | $159.91 | 2023 | Progel Applicator Spray Tips |
| Baxter Healthcare | $124.50 | 2023 | Floseal |
| Kls-Martin L.P. | $103.28 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.55 | 2024-2025 | Jardiance |
| Amgen INC. | $84.14 | 2023-2024 | Repatha |
| Novo Nordisk INC | $41.18 | 2024-2025 | Wegovy |
| Alnylam Pharmaceuticals INC. | $37.75 | 2024-2025 | Onpattro, Amvuttra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.53 | 2024 | Lifevest |
| Genzyme Corporation | $25.78 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.93 | 2025 | Triclip |
| Kiniksa Pharmaceuticals International, Plc | $18.98 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $15.80 | 2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $15.52 | 2025 | Camzyos |
| Scpharmaceuticals INC. | $15.25 | 2024 | |
| Merck Sharp & Dohme LLC | $14.49 | 2024 | Verquvo |
| Pfizer INC. | $14.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suk Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.